AIM ImmunoTech (AIM) – Litigation
-
AIM ImmunoTech (AIM) Reports Delaware Court Ruled in its Favor, Upheld Board’s Determination that Activist Group’s Nominations Are Invalid
-
AIM ImmunoTech (AIM) Bolsters Intellectual Property Estate for Ampligen with Issuance of Two Key U.S. Patents
-
-
-
-
-
Back to AIM Stock Lookup